Question to be addressed Electroporation, lipid transfection, and biolitic particle delivery systems have been used to deliver genetic material into cells but either are unsuitable for delivery to mammals; or there is lack of success in delivering the DNA

profileMichelle_Michy
MaterialsandMethods.docx

Materials and Methods

The Design

· CaDNAno open-source software

· Autodesk Maya 2015

· Addgene plasmid depository

· pCS2+8CmCherry (addgene plasmid#:34935) sequence

· Microsoft Excel

· Oligocalculator

· Bioinformatics reverse complement

The plasmid was chosen during the proposal of the research project; the anticipated plasmid was chosen from addgene, a plasmid depository. This provides easy accessibility for researchers to conduct the experiment. The plasmid is a non-viral vector derived from a Sea Urchin species, Stronglycentrotus purpuratus. The plasmid has been developed via many variants and is the pCS2+8CmCherry (addgene plasmid#:34935). (Gokirmak et al., 2012)

All the work carried out on computer was using CaDNAno and Autodesk Maya 2015. CaDNAno is a computer aided design tool, the software has been used previously, to design custom shaped 2D and 3D origami shapes. CaDNAno uses two methods of forming pleated layers of helices; Honeycomb and Square lattice. The method chosen for this design was the square lattice as it can form compact 3D origami designs. By providing a densely packed construction and natural framework for rectangles, these foundations increase the versatility and scope of 3D origami shapes for DNA nanotechnology. (Ke et al., 2009)

As the plasmid size of ‘pCS2+8CmCherry’ is 4848 base-pairs, the square lattice was designed using 35 helices, in a 6x6 format, the order of helices represents the order of folding. The base-pair length was increased to 127 from a default of 63, both forward and reverse scaffold was produced on one palette.

The forward scaffold helices were joined via crossovers to increase folding of the shape, the same procedure followed on the reverse scaffold. The forward scaffold was coloured in blue and the reverse scaffold in red.

Once the desired scaffolds were completed, the ‘autostaple’ button was selected to add staple strands that interlinked both scaffolds. Autostaple provides the staples to be added automatically, but staples are too long and may not be in desired order.

The ‘autobreak’ button was selected to change parameters of staple strands. The parameters set was; target length of 48, minimum length of 24, maximum length of 90 and minimum distance to crossover at 4. This shortened the length of the staples which were rearranged to desired locations, to increase interlinking between both scaffold and ability of rehybridization. The staples were coloured in green, black and purple. Staples in green represented connection between helices on forward scaffold, black staples were connection between forward and reverse scaffold, and purple staples represented connection between helices on reverse scaffold.

After repositioning the staple order, the forward plasmid sequence was exported from ‘addgene’ and inserted onto forward scaffold using ‘add sequence’ tab on Autodesk Maya. The sequence was then inputted into a bioinformatics reverse complement which reverses the forward sequence; this reversed sequence is inputted into the reverse scaffold.

Staple strands and forward/reverse scaffold were viewed, the base pairs were complementary of each other, the list of staples were exported into Microsoft excel.

Furthermore, Autocad Maya 2015 is a tool used for architectural design; Maya was used to edit the model so clear visualization of the nanoparticle is possible. This was carried out by using rendering tool to increase the vibrant colours of the shape, and render view was used to produce images of the frame in JPEG and TIFF file, with a 300dpi resolution.

As the limiting size of the shape is required the dimensions (height, width, length) was measured on Autodesk Maya using the measuring tool. These dimensions were measured in centimeters (cm) as the use of Autodesk Maya has been used in architectural building designs, therefore the units were changed to nanometers (nm) as Maya is a tool that produces a blueprint for the design. The conversion from cm to nm is explained in the results section; design meeting limiting size.

Protocol

· pCS2+8CmCherry Addgene (plasmid cat#34935)

· HPLC purified staple list

· Polyethylene glycol (PEG)

· Precipitation buffer

· Ultracentrifuge

· Agarose gel electrophoresis system

· TEM-imaging

· AFM-imaging

1. The plasmid sequence can be purchased from Addgene (plasmid cat#34935), and the HPLC purified oligonucleotides (staple strands) using staple list obtained from design.

2. Preparation of Plasmid sequence ‘pCS2+8CmCherry’ is carried out using Polyethylene glycol (PEG), it is efficient in separating folded designs from excess of staple strands. Precipitation using PEG is recognised as an effective method in purifying and concentrating the DNA plasmid. (Wagenbauer et al., 2017)

3. Preparation of self-assembled design is carried out using stoichiometric quantities of plasmid sequence and desired buffer solution, with excess of purified oligonucleotides as staples.

4. Add a 1:1 ratio of unpurified sample (plasmid sequence) to PEG buffer solution, thoroughly mix to achieve homogenous assembled products and buffer, the specimen is separated via ultracentrifugation.

5. The supernatant is removed, and the pellet is dissolved in a buffer, to purify the sample, further purification methods can be carried out to remove PEG residue. (Stahl et al., 2014)

6. The next stage is annealing with oligonucleotides, the melting point of the plasmid calculated is 86°C, and this is taken into consideration to identify optimum annealing conditions.

7. The samples are then processed via purified agarose gel electrophoresis to identify characterisation of the design and rehybridization properties. Mechanism of design is identified. (Marras et al., 2016)

8. TEM is used to characterise the model projection in different orientation, (XZ, YZ and XY projections), for a 3D perspective view. The AFM imaging will enable the fluorescence imaging of the plasmid and its ‘mCherry’ component. (Ke et al., 2012)

Results

Use of CaDNAno to design a nanoparticle

The design was developed using open-source software CaDNAno, this helped as a graphical interface that aids the design of DNA origami to produce 2D and 3D structures containing DNA sequences. It has helped reduce the effort to design DNA origami, by minimizing errors when carrying out tasks, having an efficient output of effort and completion of design. (Douglas et al., 2009)

Figure 1: The design of a square lattice on CaDNAno using 35 helices.

To determine whether the chosen plasmid fits the design constructed on caDNAno, the chosen plasmid had a length of 4848bp (empty backbone 4095bp). The design consisted of tightly packed square lattice structure, the default base-pair length along x-axis was set to 63 base pairs. A multiple of 32 was required, the helices was extended to a base-pair of 127. The scaffold size calculated to a total of 4444bp (35 helices x 127bp).

Nevertheless, this was smaller than the length of the plasmid, and there is difficulty in understanding what software does with excess plasmid length. As each helix contained 127bp, which majority was visually understood to complementary pair with staple strands. The remaining plasmid sequences are used for the front and end unpaired scaffold crossovers, and crossovers in the middle. (Douglas et al., 2009)

Figure 2: An illustration of the design, unpaired forward, middle and end scaffold crossovers is circled. No plasmid sequence is shown this is the location where the excess plasmid is used.

To be able rehybridization of the plasmid after delivery into cells, the design illustrates the interweaving of both the forward and reverse scaffold. This will increase the rigidity of the shape the plasmid forms, preventing it degrading in vivo, as it is densely packed with dsDNA, which enhances folding.

Figure 3: Illustrates the interweaving of both forward and reverse scaffold.

To design a structure that can encapsulate the API, this was carried out by further increasing the interlinking between forward and reverse scaffold, increasing the potential to fold. The design will fold and form a cuboidal shape that has a cavity space.

Figure 4: This figure shows the forward scaffold (blue) and reverse scaffold (red), with increased interweaving to strengthen the model and increase folding.

Once both scaffolds were designed on a single palette, it was autostapled to add staple strands to interlink both the scaffolds together. Although this method is random allocation of staples with different lengths, the autobreak function was used to change the parameters of staple strands.

Figure 5: Shows autostaples added randomly, this is further edited manually.

What does the positioning of the oligonucleotides determine? The positioning of the staples is manually altered, first by selecting ‘autobreak’ to change parameters of staple strands. The parameters set was; target length of 48, minimum length of 24, maximum length of 90 and minimum distance to crossover at 4. This is performed to alter arrangement of staples, to increase interlinking between both scaffold and enhancement of rehybridization.

Figure 6: Illustration of autobreak function, it has removed thick long staple strands.

What does the design show, and what has been achieved? The design shows the Forward scaffold in blue and Reverse scaffold in Red. The staples are colored in green, black and purple. Green staples are cross-overs between different helices on the forward scaffold, Black staples are cross-overs between helices on the Forward and Reverse scaffold, and Purple staples are cross-overs between different helices of Reverse scaffold. This is to prevent degradation of the design; therefore, number of staples are increased. This will enhance the possibility of targeted delivery.

Figure 7: The design has different colours so the model can be visualized in 3D.

To determine whether the scaffold and staple sequence are abiding base pair ruling, the entire sequence was inserted into the forward scaffold and identified whether the staples were complementary. The sequence was obtained from addgene and inserted into the forward scaffold, the sequence was then reversed using reverse complement available: https://www.bioinformatics.org/sms/rev_comp.html. The reversed sequence was inserted into the reverse scaffold and complementary base pairing was identified using zooming tool.

Figure 8: The figure shows successful addition of the forward and reverse sequence onto its allocated scaffold, it also shows the complementary paring with the staple strands.

Design meeting limiting size

DNA nanotechnology has produced small scale nanomaterial (10-6 of a millimeter), and the size of nanoparticles are in-between 10-100nm, however a limiting size of less than 50nm is relevant to be achieved whilst maintaining the functionality of the nanoparticle. (Chakraborty, Roy and Mondal, 2016)

To determine whether the 3D design on Autodesk Maya meets the limiting size, this is performed by using the ‘measuring tool’ to measure the dimensions of the height, width and length of the shape. Autodesk Maya 2015 is traditionally used for macroscale designs and measurements are in centimetres and units required is nanometres. It is known that each helix has a diameter of ~2.25nm, therefore the width of design contains 6 helices. (6x2.25= 13.5nm is the theoretical width, the measured width is 13.83nm.) (Korpelainen et al., 2017)

Figure 9: Cross section of forward scaffold with the measured width of the design.

As the model is 6x6 helices the theoretical height is also 13.5nm and the measured height is 13.76nm.

Figure 10: Height of the nanoparticle is measured at 13.76nm.

To determine how the length of the shape is meeting the limiting size, although the measured dimension is in centimetres it can be converted to nanometers, the length of each base is required to justify the measurement. As the known the measurement, each base is 3.4Å which is 0.34nm, there are 127bp in the model. Therefore, the theoretical length is 0.34nm x 127bp = 43.18nm and the measured length is 43.69nm. This is within the limiting size (10-100nm) and the ideal size (<50nm). (Seeman, 2005; Ke et al., 2009)

Figure 11: The length of the nanoparticle is within the limiting size.

Rendering using Autodesk Maya

The model design was rendered on Autodesk Maya, the forward scaffold is the front face in blue and the reverse scaffold is the reverse face in red. As it can be seen the staples are in green, black and purple. The model can be seen to have increased interlinking between the two scaffolds to increase rehybridization in vivo. The breaks in the model is identified as the cavity to load API for targeted drug delivery.

Figure 12: 3D images were rendered on Maya to visualise the physical properties of the design, the images were saved at 300dpi resolution in JPEG and TIFF format.

Discussion

The research into DNA nanotechnology has acknowledged the transition the application has developed, however there has been a failure to identify its importance and its potential applications. This is due to multiple barriers are required to be explored before nanoparticles can effectively deliver drug to target site. A key issue that requires accomplishing is successfully folding nanoparticles in accordance to design constructed on computer-aided-softwares. Distinguishing the ideal folded shape that is attempted in vitro and whether it can be identically applied in vivo for its rehybridization and folding will expand the field of DNA nanotechnology. This field has more often failed in its biological relevance and those researching in the field of DNA nanotechnology will need extensive understanding of the scope of research. Moreover, successfully identifying the gap in knowledge will develop novel designs in the field of DNA nanotechnology and can potentially be used in future medicine.

Traditionally used plasmid sequence M13 bacteriophage, was used in the design of nanostructures, longer scaffold structures were designed. However, these were challenging as large assemblies are mechanically fragile. In this study, a chosen plasmid ‘pCS2+8CmCherry’, is used to design a nanoparticle. The plasmid has a size of 4848bp which is of a smaller scale compared to M13, however there hasn’t been enough research around the plasmid. (Wang et al., 2017)

Firstly, the forward scaffold was designed on the left of the palette, with crossovers between each helix, the reverse scaffold was on the opposite side. Both scaffolds were interlinked by arrangement of helices, and the addition of the staples. The staples were manually rearranged to assist in the increase of rehybridization and prevent degradation in vivo. The increased number of staples helps to maintain a rigid structure and prevent the damage of the design in vivo.

A key focus was the limiting size of the plasmid which is of 10-100nm, with an ideal size of <50nm. The square lattice structure was used to form a 6x6 helices cross section, and the base pair length was increased to 127bp. The design has achieved the limiting size, as the width and height were designed by 6x6 helices. Korpelainen et al (2017), stated that the diameter of a single helix is 2.25nm, therefore the theoretical width and height was 13.5nm. The length also met the ideal size of <50nm as the theoretical length was 43.18nm.

Moreover, the design was rendered using Autodesk Maya, to illustrate the potential outcome of the design, the distinct features has shown the nanoparticle has potential to encapsulate API for targeted delivery.

As previously mentioned, the m13 genome is most commonly used in DNA origami; the plasmid used in this study is much smaller which can reduce fragility in comparison to previous designs. The design is within the ideal limiting size and therefore this shows it may present new potentials. Moreover, the plasmid used was the smallest identified on the repository that contains a fluorescent protein, any future research conducted using the protocol described in this study can publish a pioneering design that can be recognized via imaging systems, and possibly identified in vivo models similarly.

The Plasmid is known as an ABC transporter molecule, thus could mean that targeted drug delivery may be successful.

Gokirmark et al (2012), stated that the of the species of the plasmid, there are many significances of the proteins in development and disease. However, there is little knowledge regarding their phylogenetic origins and functional diversity. The vector has not been understood in detail of its structure and functional properties. Difficulties may be encountered during folding of nanostructure using the plasmid. Other difficulties may include the understanding of physical functions of nanoscale molecules for those that are new to this research.

It has been theoretically demonstrated that the designed plasmid is suitable to be used as a blueprint in the research of conducting this design in vitro. The design hasn’t been tested and only been developed via computer aided tools, these tools may not consider biological factors that may impact on a successful design. This has extremely limited the design as its potential use is currently unknown, so for it to be a viable in the study of DNA nanotechnology, further studies are required to be conducted to understand its reliability.

The study that was conducted may have been enhanced for further studies if a group of designs were constructed so that each design can go through trial and error in vitro settings.

Although, the potential folding pathways have been initiated by design, this doesn’t represent the actual folding pathways as this hasn’t been conducted. (Douglas et al., 2009)

Besides the limitations of the design, it has great potential for drug delivery as its essential characteristics include; compatibility, addressability and control in dimensions, shape and surface chemistry.

Doxorubicin, an anti-cancer drug has been known for its successful treatment in terminating cancerous cells; however it has a toxic effect on normal cells. It has previously been inserted in DNA complexes such as tubular and triangular DNA origami structure for targeted drug delivery to increase cytotoxicity in cancer cells, this resulted in more accumulation of API at target site and resulted to inhibition of tumor growth. (Wang et al., 2017)

Further research behind the plasmid and design conducted in this study can potentially have great outcome and contribution in DNA nanotechnology and medicine, as the plasmid species is known as transporter molecules and the sequence was the smallest used.

Conclusion

As the research conducted in DNA nanotechnology is growing continuously and has developed from its adolescence to adulthood. However, for research conducted by researchers new to the field, the understanding of the entire aspect of DNA nanotechnology is limited, as the breadth of the topic is broad, and the realistic use of nanotechnology isn’t fully understood. Moreover, researches have shown the potential of DNA nanotechnology but not completely defined due to its complexity.

Future study is required to expand the possible designs, a better architectural plan, by using multiple softwares. CanDo is a software that predicts 3D solution, shape and flexibility of programmed DNA assembly models, it enables 3D geometries and flexibilities to be predicted that isn’t possible analytically. Therefore, this software can test and predict the mechanical features of a DNA assembly model.

The study can potentially show great contribution to DNA nanotechnology as a primary design was conducted with a small plasmid sequence within the limiting size, the design can potentially be used to encapsulate API for targeted drug delivery and further advance medicine.